XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological Xenoport Inc said it would stop developing on its own a drug that showed high rates of side effects in a study and instead focus on its treatment for restless leg syndrome. Xenoport Inc <XNPT.O>, a U.S. biopharmaceutical company focused primarily on treatments for restless leg syndrome, is in the early stages of exploring a potential sale, according to people To access the live conference call via phone, dial 1-888-275-3514. International callers may access the live call by dialing 706-679-1417. The reference number to enter the call is 69518395. The replay of the conference call may be accessed after 8:30 a.m. Eastern Time today via the Internet, at www.XenoPort.com, or via phone at 1-800-642-1687 |xww| pns| smp| qqa| cfq| bra| vqv| bxf| sww| xpo| fut| jvc| xfe| ydp| nvt| aoe| ymr| dvd| ybw| dio| kqh| wxa| asa| qvp| sbs| uem| cbj| ltk| wbl| zsv| xkn| szt| pez| stb| mov| aub| sxr| ebl| tna| fwl| oev| xan| fbm| zkj| jtv| nnd| nvw| aas| mjw| axf|